Human Biospecimens

A human biospecimen is any biological material collected from a human donor for research use. Human biospecimens may include FFPE tissue blocks, fresh tissue, frozen tissue, whole blood, plasma, serum, PBMCs, buffy coat, urine, saliva, bone marrow, DNA, RNA, and matched sample sets. These specimens are widely used in drug discovery, diagnostic development, biomarker research, translational medicine, and clinical research. Human specimens such as blood and tissue are considered essential materials for biomedical research

iBioSpecimen is a human biospecimen provider supporting pharmaceutical companies, biotechnology firms, CROs, diagnostic manufacturers, academic researchers, and clinical research organizations with access to ethically sourced human biological samples. iBioSpecimen helps researchers source human tissue samples, blood samples, biofluids, matched biospecimens, FFPE blocks, NGS-screened tissue blocks, and clinically annotated research specimens across the USA, UK, Europe, and Asia.

Human biospecimens can be collected through various methods, including blood draws, biopsies, surgical procedures, and non-invasive techniques like saliva or urine samples. The collection method depends on the research goals and the type of biospecimen needed.

Yes. iBioSpecimen supports researchers, CROs, diagnostic companies, biotech firms, and pharmaceutical organizations looking for human biospecimens in the USA. We help source FFPE tissue blocks, blood samples, plasma, serum, PBMCs, matched biospecimen sets, and disease-specific human samples for biomedical research and assay development.

Yes. iBioSpecimen supports human biospecimen sourcing for research organizations in the UK. We work with clients requiring human tissue samples, blood samples, FFPE blocks, matched biospecimens, and biofluid samples for biomarker research, molecular diagnostics, oncology studies, and translational research.

Yes. iBioSpecimen supports biospecimen procurement for research projects across Europe. We help researchers source clinically relevant human biospecimens, including tissue, blood, plasma, serum, PBMCs, and matched sample sets, with attention to ethical sourcing, de-identification, documentation, and research-use requirements.

Yes. iBioSpecimen supports human biospecimen sourcing across Asia for global biomedical research projects. Asian human biospecimens can be valuable for population diversity studies, disease prevalence research, oncology studies, genetic variation analysis, biomarker validation, and diagnostic assay development.

Researchers choose iBioSpecimen because we provide access to diverse human biospecimen types, disease-specific cohorts, matched sample sets, clinical annotations, flexible sourcing options, and research-focused project support. Our goal is to help CROs, pharma companies, biotech firms, and diagnostic developers access high-quality human biospecimens for reliable research outcomes

Human biospecimens are used for drug discovery, biomarker discovery, companion diagnostic development, molecular assay validation, immunology studies, oncology research, genomics, transcriptomics, proteomics, metabolomics, liquid biopsy research, digital pathology, AI model development, and clinical translational research.

Yes. iBioSpecimen provides human tissue samples for research, including FFPE tissue blocks, FFPE curls, FFPE slides, fresh tissue, frozen tissue, normal tissue, tumor tissue, and disease-state tissue samples. These samples can support pathology research, molecular testing, IHC validation, FISH testing, NGS studies, and biomarker analysis.

Yes. iBioSpecimen provides FFPE tissue blocks for research use. FFPE blocks are commonly used for histology, immunohistochemistry, molecular pathology, DNA/RNA extraction, NGS testing, FISH testing, tissue microarray development, and biomarker validation.

Yes. iBioSpecimen provides human blood samples for research use, including whole blood, plasma, serum, PBMCs, buffy coat, and matched blood-derived biospecimens. These samples support biomarker studies, diagnostic development, immune profiling, liquid biopsy research, and molecular assay validation..

Yes. Human whole blood samples can be sourced from healthy donors or disease-state donors depending on project requirements. Whole blood samples are commonly used for immune profiling, hematology research, DNA/RNA extraction, pharmacodynamic studies, biomarker validation, and diagnostic assay development.

Yes. Human plasma samples are available for research applications such as ctDNA analysis, cfDNA research, liquid biopsy validation, proteomics, metabolomics, circulating biomarker studies, pharmacokinetic research, and diagnostic assay development.

Yes. Human serum samples can be provided for immunoassay development, serology studies, protein biomarker analysis, antibody detection, inflammation research, infectious disease research, and diagnostic test validation.

Yes. PBMC samples may be available from healthy donors or disease-state donors. PBMCs are commonly used in immunology research, vaccine development, oncology studies, immune monitoring, flow cytometry, T-cell studies, cytokine profiling, and cell therapy research.

Yes. Buffy coat samples can be sourced for research use. Buffy coat is often used for germline DNA extraction, genomic testing, tumor-normal comparison, inherited variant research, and molecular assay development.

Yes. iBioSpecimen provides matched biospecimen sample sets, including FFPE tissue with matched whole blood, FFPE with matched plasma, FFPE with matched serum, FFPE with matched PBMCs, tumor tissue with matched normal tissue, and tissue samples matched with clinical data, pathology reports, IHC results, or molecular findings.

Matched human biospecimens are two or more sample types collected from the same donor or patient. For example, a matched set may include tumor FFPE tissue, whole blood, plasma, serum, buffy coat, and clinical data from the same individual. Matched biospecimens are useful for comparing tissue biomarkers with circulating biomarkers.

Yes. iBioSpecimen can support research projects requiring FFPE tissue blocks matched with blood samples from the same donor. This combination is valuable for oncology research, tumor-normal studies, liquid biopsy validation, immune profiling, and companion diagnostic development.

Yes. FFPE tissue with matched plasma may be sourced for research projects. This sample combination is commonly used to compare tumor tissue biomarkers with circulating tumor DNA, cfDNA, plasma proteins, or other blood-based biomarkers.

Yes. iBioSpecimen can support projects requiring NGS-screened FFPE tissue blocks. These samples may be selected based on molecular status, mutation profile, gene fusion, amplification, deletion, tumor type, or biomarker expression, depending on availability and testing requirements.

Yes. iBioSpecimen provides cancer biospecimens for research, including FFPE tumor blocks, tumor slides, frozen tumor tissue, blood, plasma, serum, PBMCs, matched tumor-normal sets, and clinically annotated oncology samples. Cancer biospecimens are used in biomarker discovery, NGS validation, IHC testing, FISH testing, liquid biopsy research, and drug development.

iBioSpecimen may support many cancer indications, including non-small cell lung cancer, breast cancer, colorectal cancer, pancreatic cancer, prostate cancer, ovarian cancer, gastric cancer, liver cancer, melanoma, head and neck cancer, bladder cancer, renal cancer, lymphoma, leukemia, sarcoma, and rare tumors depending on sample availability.

Yes. Normal human biospecimens may be available from healthy donors or non-diseased tissue sources. These samples are commonly used as controls in biomarker research, assay development, genomic studies, immunology research, and diagnostic validation.

Yes. Disease-state human biospecimens can be sourced for research projects involving cancer, autoimmune disease, infectious disease, diabetes, cardiovascular disease, neurological disease, inflammatory disease, liver disease, kidney disease, respiratory disease, and other clinical conditions.

Yes. iBioSpecimen can support custom biospecimen collection based on specific project requirements, including disease indication, sample type, donor criteria, collection tube, processing method, storage condition, clinical data, biomarker status, geographic source, and shipment requirements.

Yes. Prospective biospecimen collection can be arranged when researchers need samples collected according to a specific protocol. This is useful for fresh blood, fresh tissue, matched sample sets, longitudinal collection, pre-treatment and post-treatment samples, and disease-specific patient recruitment.

Yes. iBioSpecimen can help researchers access banked biospecimens where available. Banked samples may include archived FFPE tissue blocks, frozen tissue, plasma, serum, PBMCs, buffy coat, and clinically annotated disease-state specimens.

Yes. Human biospecimens should be sourced with appropriate ethical oversight, informed consent, institutional authorization, IRB/ethics committee approval, or waiver of consent where applicable. Ethical sourcing, privacy protection, and proper specimen handling are key requirements in human biospecimen research. Pfizer’s biospecimen policy also emphasizes adherence to consent terms, contracts, training, receipt, storage, use, and disposition of biospecimens

Yes. iBioSpecimen provides human biospecimens in a de-identified or coded format for research use. De-identification helps protect donor privacy while allowing researchers to access relevant clinical, demographic, pathological, and molecular information where available.

Yes. iBioSpecimen can support projects requiring IRB-approved, ethics-approved, or institutionally authorized biospecimens. Documentation may include informed consent confirmation, IRB approval, ethics committee approval, waiver of consent, de-identification statement, research-use-only declaration, or material transfer documents depending on the sample source and project.

Available documentation may include sample manifest, pathology report, clinical summary, collection protocol, processing details, storage history, consent confirmation, IRB/ethics approval, waiver documentation, chain-of-custody record, research-use-only declaration, and Certificate of Analysis where applicable

Clinical data may include age, gender, diagnosis, disease stage, grade, histology, tissue site, treatment history, medication status, therapy response, recurrence status, survival data, pathology findings, IHC results, molecular reports, laboratory values, and collection date depending on availability and compliance permissions.

Yes. Many tissue-based biospecimens can be supplied with de-identified pathology reports or pathology summaries where available. Pathology data may include diagnosis, tissue type, tumor percentage, necrosis percentage, histological subtype, grade, stage, and relevant biomarker information.

Yes. Biospecimens may be available with molecular reports or can be tested for specific biomarkers based on project needs. Molecular data may include NGS, PCR, qPCR, FISH, IHC, mutation status, fusion status, amplification, deletion, MSI, TMB, or other biomarker results.

Yes. iBioSpecimen can help source biomarker-positive biospecimens for research studies. Examples may include EGFR-mutated NSCLC, ALK-positive tumors, ROS1-positive tumors, KRAS-mutated cancers, HER2-positive tumors, MSI-high tumors, BRCA-mutated cancers, MTAP/CDKN2A-deleted tumors, PD-L1-positive tissue, and other molecularly defined cohorts.

Yes. Human biospecimens are critical for companion diagnostic development. iBioSpecimen can support projects requiring biomarker-positive tissue, matched plasma, molecular data, IHC results, FISH-confirmed cases, NGS-screened FFPE blocks, and clinically annotated cohorts for assay development and validation.

Yes. iBioSpecimen provides biospecimens that support drug discovery and translational medicine programs. Researchers can use human tissue, blood, plasma, serum, PBMCs, and matched sample sets to study disease biology, target expression, pharmacodynamic markers, resistance mechanisms, and patient stratification.

Yes. iBioSpecimen can support diagnostic assay validation using human tissue samples, blood samples, plasma, serum, PBMCs, FFPE blocks, matched samples, disease-state cohorts, and biomarker-characterized specimens. These samples are useful for molecular diagnostics, immunoassays, IHC, FISH, PCR, NGS, and liquid biopsy validation.

Yes. iBioSpecimen can support liquid biopsy research with matched FFPE tissue, plasma, whole blood, buffy coat, serum, and molecularly characterized samples. These specimens can be used for ctDNA, cfDNA, circulating tumor cell, exosome, methylation, and blood-based biomarker studies.

Yes. Human biospecimens from iBioSpecimen can support genomics and NGS research, including targeted sequencing, whole exome sequencing, whole genome sequencing, RNA sequencing, fusion testing, tumor-normal sequencing, liquid biopsy analysis, and molecular assay validation.

Yes. Human plasma, serum, tissue, and other biofluid samples can support proteomics research. These samples are useful for protein biomarker discovery, immunoassay development, disease pathway analysis, drug response studies, and translational research.

Yes. iBioSpecimen can support digital pathology and AI research with FFPE tissue blocks, H&E slides, IHC slides, scanned whole slide images, pathology reports, molecular data, and clinical annotations. These datasets can support AI model training, biomarker prediction, computational pathology, and image-based research.

Yes. iBioSpecimen can support research projects requiring whole slide images generated from H&E, IHC, or special stain slides. Whole slide images can be matched with FFPE blocks, pathology reports, molecular results, and clinical data where available

Yes. Tissue microarrays may be available or custom-built using selected FFPE tissue blocks. TMAs are useful for high-throughput IHC validation, biomarker screening, antibody testing, disease comparison, and pathology research.

Yes. Rare disease biospecimens may be sourced through custom procurement depending on indication, donor availability, site access, documentation requirements, and project timeline. Rare disease projects usually require flexible criteria and prospective sourcing.

Yes. iBioSpecimen supports biospecimen sourcing across the USA, UK, Europe, and Asia. Multi-country sourcing can help researchers access diverse donor populations, increase sample availability, compare regional disease biology, and support global research programs.

Yes. International shipment can be coordinated based on sample type, destination country, temperature requirements, import/export documentation, and research-use regulations. FFPE samples, frozen samples, fresh samples, and biofluids may require different shipping conditions and documentation.

Biospecimens are shipped according to sample type and study requirements. FFPE tissue blocks and slides are usually shipped at ambient temperature. Frozen tissue, plasma, serum, PBMCs, DNA, and RNA may require dry ice or temperature-controlled shipment. Fresh blood and fresh tissue require time-sensitive logistics.

Yes. Urgent biospecimen requests may be supported depending on sample type, disease indication, availability, and documentation requirements. Banked FFPE blocks or frozen inventory may be faster to source, while fresh or highly specific disease-state collections may require more time.

Yes. Researchers can request biospecimens based on donor criteria such as age, gender, ethnicity, diagnosis, disease stage, histology, tumor percentage, treatment history, smoking status, medication history, biomarker status, geographic region, and sample collection date.

Yes. Longitudinal biospecimen collection can be arranged for studies requiring multiple time points from the same donor or patient. These collections are useful for treatment response monitoring, disease progression studies, recurrence studies, pharmacodynamic analysis, and biomarker tracking.

Yes. Pre-treatment and post-treatment biospecimens may be available or collected prospectively depending on study design and site access. These matched time-point samples are useful for therapy response research, resistance mechanism studies, and biomarker monitoring.

Yes. iBioSpecimen supports CROs with human biospecimens for clinical research, assay validation, biomarker studies, pharma projects, diagnostic development, and translational research. We can help CROs source samples according to defined protocols, documentation requirements, and project timelines.

Yes. iBioSpecimen supports pharmaceutical companies with disease-specific human biospecimens, matched sample sets, biomarker-positive samples, clinical annotations, tissue and blood samples, and molecularly characterized cohorts for drug development, patient stratification, and translational research.

Yes. iBioSpecimen supports biotech companies developing diagnostics, therapeutics, AI platforms, molecular assays, immunology tools, cell-based technologies, and precision medicine solutions. Human biospecimens can help accelerate product development and validation.

You can submit your project requirements, including sample type, disease indication, number of cases, donor criteria, sample format, biomarker status, clinical data needs, documentation requirements, shipping destination, and timeline. iBioSpecimen will review feasibility and provide availability, pricing, estimated timeline, and next steps.

Obtaining the right human biospecimens can be challenging, especially when a study requires specific disease indications, donor demographics, sample formats, clinical annotations, collection protocols, or geographic diversity. iBioSpecimen helps streamline this process through a broad network of hospitals, laboratories, blood centers, clinics, biobanks, pathology centers, and research partners across the United States, Europe, Asia, and other international regions.

Our global network allows researchers to access a wide variety of human biospecimen types, including clinical remnants, banked samples, prospectively collected specimens, disease-specific samples, and matched sample sets. This flexible sourcing model helps support both small pilot studies and large-scale research or validation programs.

By working with multiple collection partners, iBioSpecimen can assist with biospecimen procurement across different therapeutic areas, including oncology, infectious diseases, autoimmune disorders, cardiovascular diseases, neurological conditions, metabolic disorders, inflammatory diseases, rare diseases, and other clinical indications.

Accordion iBioSpecimen can assist with the procurement of multiple types of human biospecimens depending on your research or development needs. These may include:Content

for pathology research, biomarker validation, immunohistochemistry, molecular testing, spatial biology, and companion diagnostic development.

for genomics, transcriptomics, proteomics, biomarker discovery, and molecular research applications.

from healthy and diseased donors for genetic research, molecular diagnostics, immune profiling, infectious disease studies, liquid biopsy development, and IVD assay validation.

for biomarker discovery, pharmacokinetic studies, serology testing, proteomics, diagnostic assay development, and clinical research.

for immunology research, cell-based assays, vaccine research, immune profiling, and drug development programs.

including matched tissue and blood, matched tumor and normal tissue, matched plasma and serum, matched primary and metastatic tumor samples, and other paired specimen combinations.

based on custom study protocols, disease indications, donor criteria, collection volume, processing requirements, and shipping timelines.

Human biospecimens are widely used across biomedical and clinical research programs. iBioSpecimen supports researchers who require reliable biological samples for applications such as biomarker discovery, oncology research, molecular diagnostics, assay development, IVD validation, companion diagnostic development, drug discovery, translational research, clinical trial support, genetic testing, liquid biopsy studies, immunology research, infectious disease research, and medical device validation.

For oncology research, human biospecimens such as FFPE tissue blocks, tumor tissue sections, plasma, serum, whole blood, and matched tumor-normal samples can support biomarker analysis, mutation testing, IHC validation, FISH testing, NGS assay development, tumor microenvironment studies, and treatment response research.

For molecular diagnostics and IVD development, biospecimens are essential for assay optimization, analytical validation, clinical validation support, sensitivity testing, specificity testing, performance evaluation, and regulatory documentation. iBioSpecimen helps diagnostic companies access relevant human samples according to the requirements of their development and validation programs.

For pharmaceutical and biotech research, disease-specific biospecimens can support drug discovery, target validation, pharmacogenomics, companion diagnostic development, patient stratification, translational medicine, and biomarker-driven clinical research.

iBioSpecimen can assist with sourcing human biospecimens from healthy donors as well as patients with specific disease conditions. Depending on availability and project requirements, disease-specific biospecimens may include oncology samples, infectious disease samples, autoimmune disease samples, inflammatory disease samples, cardiovascular disease samples, metabolic disease samples, neurological disease samples, gastrointestinal disease samples, respiratory disease samples, and rare disease specimens.

Researchers may request samples based on disease type, diagnosis, stage, grade, treatment history, donor demographics, sample format, collection date, preservation method, storage condition, and available clinical data. For pathology-based research, FFPE tissue blocks and tissue sections may be sourced with diagnosis confirmation, tumor percentage, necrosis percentage, tissue site, histological subtype, and other relevant pathology details where available.

FFPE human biospecimens are among the most commonly requested sample types for pathology, oncology, molecular diagnostics, and biomarker research. Formalin-fixed paraffin-embedded tissue blocks and sections are widely used in immunohistochemistry, histology, FISH testing, DNA/RNA extraction, NGS testing, mutation analysis, spatial transcriptomics, and companion diagnostic development.

iBioSpecimen can assist with sourcing FFPE tissue blocks, FFPE tissue scrolls, unstained slides, stained slides, tumor tissue samples, normal tissue samples, matched tumor-normal tissue, primary tumor samples, metastatic tumor samples, and disease-specific FFPE specimens. These samples can support pharmaceutical companies, CROs, diagnostic manufacturers, and academic researchers working on oncology and pathology-based research programs.

Different research applications require different sample formats. Some studies require fresh samples collected within a defined time window, while others may require banked specimens with historical clinical information. iBioSpecimen supports multiple sourcing models depending on the study design.

Fresh human biospecimens may be suitable for cell-based assays, immune profiling, PBMC isolation, RNA-sensitive studies, and applications where sample viability or processing time is important. Frozen biospecimens may be used for molecular research, genomics, proteomics, and biomarker studies. Banked biospecimens may support retrospective studies, assay development, and feasibility testing. Prospective collections may be arranged when a study requires custom donor criteria, collection tubes, processing protocols, storage conditions, or shipment timelines.

Every research project has unique sample requirements. iBioSpecimen supports custom biospecimen procurement based on your specific study protocol. Clients may request samples according to donor age, gender, ethnicity, diagnosis, disease stage, treatment status, sample type, sample volume, anticoagulant type, tissue format, storage condition, processing time, geographic region, and documentation requirements.

For complex projects, iBioSpecimen can help support multi-site sourcing, rare indication searches, matched sample collection, longitudinal sample procurement, and large-volume biospecimen programs. Whether you need a small number of samples for assay feasibility or a larger cohort for validation studies, our team can help identify suitable sourcing options.

When available, human biospecimens may be provided with de-identified clinical data and sample annotations. The level of data depends on sample type, collection site, disease indication, consent permissions, and project scope. Available data may include donor demographics, diagnosis, disease stage, pathology details, treatment information, laboratory values, collection date, storage condition, and relevant clinical history.

Annotated biospecimens are especially valuable for translational research, biomarker discovery, diagnostic validation, drug development, and precision medicine studies. iBioSpecimen helps researchers access samples with relevant supporting information whenever available and ethically permitted.

iBioSpecimen focuses on ethical sourcing, donor privacy, sample traceability, protocol-based collection, and reliable logistics. Human biospecimens are sourced through established clinical and research networks, with attention to documentation, sample handling, collection standards, and research-use requirements.

Our approach is designed to help researchers reduce delays, improve access to required sample types, and support high-quality research outcomes. We understand the importance of sample integrity, donor diversity, traceability, and timely delivery in biomedical research and diagnostic development.

iBioSpecimen works with a wide range of organizations, including pharmaceutical companies, biotechnology firms, CROs, diagnostic manufacturers, medical device companies, academic institutions, clinical researchers, and translational medicine teams. Our biospecimen sourcing services are designed to support early discovery research, assay development, validation studies, clinical research programs, and product development pipelines.

Whether your team is developing a new diagnostic assay, validating an IVD product, studying disease biomarkers, conducting oncology research, building a liquid biopsy platform, or supporting a clinical trial, iBioSpecimen can help source human biospecimens that match your research and development needs.

If you are looking for high-quality human biospecimens for research, iBioSpecimen can help you identify suitable sample options based on your project requirements. Share your required sample type, disease indication, donor criteria, sample quantity, processing requirements, clinical data needs, and shipping destination, and our team will review availability through our global sourcing network.

iBioSpecimen is committed to helping researchers, pharmaceutical companies, biotech firms, CROs, and diagnostic manufacturers access the right human biospecimens for biomedical research, clinical studies, assay development, molecular diagnostics, and medical innovation.

At iBioSpecimen, we support pharmaceutical companies, biotechnology firms, CROs, diagnostic manufacturers, academic researchers, clinical laboratories, and medical device companies with access to ethically sourced and well-characterized human biospecimens. Our goal is to simplify biospecimen procurement by providing access to diverse donor populations, global collection sites, disease-specific sample availability, and protocol-based sourcing.